Glen Eagle Advisors, LLC Novartis Ag Transaction History

Glen Eagle Advisors, LLC

  • $604 Billion
  • Q1 2025

A detailed history of Glen Eagle Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 1,018 shares of NVS stock, worth $115,247. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,018
Previous 1,040 2.12%
Holding current value
$115,247
Previous $101 Million 12.14%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$97.14 - $115.57 $2,137 - $2,542
-22 Reduced 2.12%
1,018 $113 Million
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $77,758 - $90,190
840 Added 420.0%
1,040 $111 Million
Q1 2024

Jul 03, 2024
BUY
$95.27 - $108.47 $99,080 - $112,808
1,040 New
1,040 $101 Million
Q4 2023

Aug 13, 2024
BUY
$92.27 - $101.54 $65,696 - $72,296
712 Added 256.12%
990 $100 Million
Q3 2023

Aug 13, 2024
SELL
$94.73 - $105.13 $94 - $105
-1 Reduced 0.36%
278 $28.4 Million
Q2 2023

Aug 13, 2024
BUY
$92.52 - $104.91 $92 - $104
1 Added 0.36%
279 $28.1 Million
Q1 2023

Aug 13, 2024
SELL
$80.03 - $92.81 $6,002 - $6,960
-75 Reduced 21.25%
278 $25.6 Million
Q4 2021

Aug 13, 2024
SELL
$79.7 - $88.13 $7,970 - $8,813
-100 Reduced 22.08%
353 $30.9 Million
Q2 2021

Aug 13, 2024
BUY
$85.24 - $94.15 $2,557 - $2,824
30 Added 7.09%
453 $41.4 Million
Q4 2020

Aug 13, 2024
SELL
$78.07 - $94.43 $48,169 - $58,263
-617 Reduced 59.33%
423 $40 Million
Q2 2020

Aug 13, 2024
BUY
$80.93 - $91.1 $5,665 - $6,377
70 Added 21.21%
400 $35 Million
Q4 2019

Aug 13, 2024
BUY
$84.35 - $95.37 $2,783 - $3,147
33 Added 11.11%
330 $31.3 Million
Q1 2019

Aug 13, 2024
SELL
$75.32 - $86.15 $55,962 - $64,009
-743 Reduced 71.44%
297 $28.6 Million
Q3 2018

Aug 13, 2024
BUY
$66.94 - $77.43 $1,472 - $1,703
22 Added 11.0%
222 $19.1 Million
Q2 2018

Aug 13, 2024
SELL
$64.91 - $73.36 $1.04 Million - $1.17 Million
-15,970 Reduced 98.76%
200 $15.1 Million
Q1 2018

Aug 14, 2024
SELL
$70.39 - $84.15 $59,127 - $70,686
-840 Reduced 80.77%
200 $16.2 Million
Q1 2018

Aug 13, 2024
BUY
$70.39 - $84.15 $1.12 Million - $1.34 Million
15,970 Added 7985.0%
16,170 $16.2 Million
Q3 2017

Aug 13, 2024
SELL
$74.14 - $77.27 $62,277 - $64,906
-840 Reduced 80.77%
200 $17.2 Million
Q4 2016

Aug 12, 2024
SELL
N/A
-640
400 $29.1 Million

Others Institutions Holding NVS

# of Institutions
1,523
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $244B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email